Research opportunity- Volunteers needed to assess the therapeutic effect of a Novel Probiotic-based Intervention in sugar levels
The effects of a Multi-strain Probiotic on Metabolic Biomarkers in Pre-diabetic Adults - Randomised Double-blinded, Placebo Controlled Pilot study
Probiotics are live bacteria and yeasts that may help to prevent or treat some illnesses. Probiotic-based interventions have shown to keep your gut healthy and could be used to support standard lifestyle advice to manage obesity and type 2 diabetes.
We are conducting a clinical trial to investigate the therapeutic effect of a multi-strain probiotic in improving blood sugar levels and lipids and reducing inflammatory markers in overweight men and women with known higher glucose levels.
To qualify for participation you must be:
- 18 years or older
- have a BMI >25 kg/m2 and
- have pre-diabetes or being recently diagnosed with type 2 diabetes (within 12 months).
An oral glucose tolerance test will be performed to confirm if you are eligible.
Those who meet the criteria will be randomised to either the probiotic or placebo groups for 12 weeks duration. Four visits are required at the Charles Perkins Centre Clinic, The University of Sydney. Stool samples and blood samples will be required before supplementation and at week 12.
For more information please contact: Talia Palacios on 02 8627 1962 / 04 5018 0801 / email@example.com
This study has been approved by the Sydney Local Health District Human Research Ethics Committee (RPAH zone). Protocol No X14-0369 & HREC/14/RPAH/492.
The University of Sydney